drugdeliverybusiness11d
Medtronic says it has next-gen insulin pumps on the way, more to come from diabetes business
The Diabetes business unit at Medtronic (NYSE:MDT) could have some exciting offering in the pipeline, company officials say.
Frontiers2mon
The success of insulin pump therapy: importance of education of patients and health professionals
There were no VEO pump failures during this period. From 2022 onward, MiniMed 640G and MiniMed 740G pumps are available to patients under 18 years of age, while Ypsomed insulin pumps are allocated to ...